Cargando…
Vault Nanocapsules as Adjuvants Favor Cell-Mediated over Antibody-Mediated Immune Responses following Immunization of Mice
BACKGROUND: Modifications of adjuvants that induce cell-mediated over antibody-mediated immunity is desired for development of vaccines. Nanocapsules have been found to be viable adjuvants and are amenable to engineering for desired immune responses. We previously showed that natural nanocapsules ca...
Autores principales: | Kar, Upendra K., Jiang, Janina, Champion, Cheryl I., Salehi, Sahar, Srivastava, Minu, Sharma, Sherven, Rabizadeh, Shahrooz, Niazi, Kayvan, Kickhoefer, Valerie, Rome, Leonard H., Kelly, Kathleen A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394761/ https://www.ncbi.nlm.nih.gov/pubmed/22808011 http://dx.doi.org/10.1371/journal.pone.0038553 |
Ejemplares similares
-
Novel CCL21-Vault Nanocapsule Intratumoral Delivery Inhibits Lung Cancer Growth
por: Kar, Upendra K., et al.
Publicado: (2011) -
A Vault Nanoparticle Vaccine Induces Protective Mucosal Immunity
por: Champion, Cheryl I., et al.
Publicado: (2009) -
Identification of an immune gene expression signature associated with favorable clinical features in Treg-enriched patient tumor samples
por: Givechian, Kevin B., et al.
Publicado: (2018) -
The p80 homology region of TEP1 is sufficient for its association with the telomerase and vault RNAs, and the vault particle
por: Poderycki, Michael J., et al.
Publicado: (2005) -
The Telomerase/Vault-Associated Protein Tep1 Is Required for Vault RNA Stability and Its Association with the Vault Particle
por: Kickhoefer, Valerie A., et al.
Publicado: (2001)